ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

2-Dicyclohexylphosphino-2',4',6'-triisoprophylbiphenyl → N,N-Diethyl-2-(4-{2-fluoro-4-[2-oxo-2-(2-phenyl-piperidin-1-yl)-ethyl]-phenyl}-piperazin-1-yl)-2-phenyl-acetamide

HRID 1927634
ノート
印刷プレビュー

反応式

HRID 1927634 の反応式
Cl[C:2]1[CH:7]=[CH:6][C:5]([CH2:8][C:9]([N:11]2[CH2:16][CH2:15][CH2:14][CH2:13][CH:12]2[C:17]2[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=2)=[O:10])=[CH:4][C:3]=1[F:23].[CH2:24]([N:26]([CH2:42][CH3:43])[C:27](=[O:41])[CH:28]([C:35]1[CH:40]=[CH:39][CH:38]=[CH:37][CH:36]=1)[N:29]1[CH2:34][CH2:33][NH:32][CH2:31][CH2:30]1)[CH3:25].CC(C1C=C(C(C)C)C(C2C=CC=CC=2P(C2CCCCC2)C2CCCCC2)=C(C(C)C)C=1)C.CC(C)([O-])C.[Na+]>C1(C)C=CC=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd]>[CH2:42]([N:26]([CH2:24][CH3:25])[C:27](=[O:41])[CH:28]([N:29]1[CH2:34][CH2:33][N:32]([C:2]2[CH:7]=[CH:6][C:5]([CH2:8][C:9](=[O:10])[N:11]3[CH2:16][CH2:15][CH2:14][CH2:13][CH:12]3[C:17]3[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=3)=[CH:4][C:3]=2[F:23])[CH2:31][CH2:30]1)[C:35]1[CH:40]=[CH:39][CH:38]=[CH:37][CH:36]=1)[CH3:43]
参加物実験手順後処理出典と根拠反応ノート

参加物

7

反応物 4

HCID 111557942-Dicyclohexylphosphino-2',4',6'-triisoprophylbiphenylHCID 23676156Sodium t-butoxideHCID 66663821N,N-diethyl-2-phenyl-2-piperazin-1-yl-acetamideHCID 693044472-(4-Chloro-3-fluoro-phenyl)-1-(2-phenyl-piperidin-1-yl)-ethanone

生成物 1

HCID 58870682N,N-Diethyl-2-(4-{2-fluoro-4-[2-oxo-2-(2-phenyl-piperidin-1-yl)-ethyl]-phenyl}-piperazin-1-yl)-2-phenyl-acetamide
収率 16.4%

試薬・触媒・溶媒 2

HCID 9811564Bis(dibenzylideneacetone)palladium触媒HCID 1140Toluene溶媒

実験手順

A solution of 2-(4-chloro-3-fluoro-phenyl)-1-(2-phenyl-piperidin-1-yl)-ethanone (0.25 g, 0.75 mmol), N,N-diethyl-2-phenyl-2-piperazin-1-yl-acetamide (0.23 g, 0.82 mmol), Pd2(dba)3 (0.01 g, 0.0075 mmol), XPhos (0.01 g, 0.015 mmol), and sodium t-butoxide (0.11 g, 1.05 mmol) in toluene (2 mL) was irradiated by microwave at 120° C. for 20 min. The solution was allowed to cool, filtered through diatomaceous earth, washing with DCM (10 mL). The filtrate was concentrated and the residue was purified by SiO2 column chromatography (2 M NH3 in MeOH:DCM) to provide the title compound (0.07 g, 16%). MS: 571.7. 1H NMR (CDCl3): 7.48-7.46 (m, 2H), 7.38-7.35 (m, 4H), 7.28-7.23 (m, 2H), 7.19-7.15 (m, 4H), 6.90-6.89 (m, 2H), 3.70 (bs, 2H), 3.49-3.40 (m, 6H), 3.31-3.12 (m, 8H), 2.70-2.69 (m, 4H), 1.60-1.59 (m, 3H), 1.10-1.04 (m, 6H).

後処理

  1. temperatureto cool
  2. filtrationfiltered through diatomaceous earth
  3. washwashing with DCM (10 mL)
  4. concentrationThe filtrate was concentrated
  5. customthe residue was purified by SiO2 column chromatography (2 M NH3 in MeOH:DCM)

出典と根拠

ORDレコード
ord-2b1a036168c742dbbc6a7bf38cef0c6a
出典データセット
uspto-grants-2012_05
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08183239B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート